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A B S T R A C T
Lactosucrose is a synthetic trisaccharide composed of galactose, glucose and fructose. This
compound is obtained through enzymatic synthesis using lactose and sucrose as sub-
strates.The enzymes involved in the process are able to catalyse both hydrolysis and transfer
reactions. The yield and productivity of the process are usually affected by the occurrence
of parallel hydrolysis of the newly formed product (lactosucrose). Therefore, it is impor-
tant to find efficient strategies to avoid or minimize product degradation. Furthermore, in
the last decades the demand for lactosucrose has significantly increased. This compound
is considered a potential prebiotic and several beneficial effects associated to its consump-
tion have been described. As a result, it has been included in the formulations of functional
foods. This review covers the most relevant information about lactosucrose, including its
synthesis and purification, beneficial effects at physiological level, and also its potential
applications.
© 2015 Elsevier Ltd. All rights reserved.
Keywords:
Lactosucrose
Lactose
Sucrose
Prebiotic
Enzymatic synthesis
Contents
1. Introduction ........................................................................................................................................................................................ 75
2. Lactosucrose properties and stability ............................................................................................................................................. 75
3. Lactosucrose production ................................................................................................................................................................... 76
3.1. Integrated process of enzyme and lactosucrose production ........................................................................................... 77
3.1.1. Free enzyme .................................................................................................................................................................. 77
3.1.2. Whole cells .................................................................................................................................................................... 80
3.2. Lactosucrose production using commercial/industrial enzyme mixtures .................................................................... 81
3.2.1. Free enzyme .................................................................................................................................................................. 81
3.2.2. Immobilized enzyme ................................................................................................................................................... 81
4. Lactosucrose quantification and purification ................................................................................................................................ 83
* Corresponding author. CEB – Centre of Biological Engineering, Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Tel.: +351 601 972; fax: +351 253 604 429.
E-mail address: sarasilverio@deb.uminho.pt (S.C. Silvério).
http://dx.doi.org/10.1016/j.jff.2015.09.014
1756-4646/© 2015 Elsevier Ltd. All rights reserved.
J o u rna l o f Func t i ona l F ood s 1 9 ( 2 0 1 5 ) 7 4 – 9 0
Available online at www.sciencedirect.com
journal homepage: www.elsevier.com/ locate / j ff
ScienceDirect
5. Benefits associated to lactosucrose ingestion ............................................................................................................................... 83
5.1. In vitro studies .......................................................................................................................................................................... 84
5.2. In vivo studies with animals .................................................................................................................................................. 84
5.3. In vivo studies with humans ................................................................................................................................................. 85
6. Potential applications of lactosucrose ............................................................................................................................................ 85
7. General conclusions and future perspectives ............................................................................................................................... 86
Acknowledgements ........................................................................................................................................................................... 86
References ........................................................................................................................................................................................... 86
1. Introduction
The concept of prebiotic was first introduced in 1995 by Gibson
and Roberfroid (1995). However, the original concept was
updated and now prebiotics are defined as: “a selectively fer-
mented ingredient that allows specific changes, both in the composition
and/or activity of the gastrointestinal microflora that confers ben-
efits upon host well-being and health” (Gibson, Probert, Loo, Rastall,
& Roberfroid, 2004). In general, prebiotics are carbohydrate com-
pounds; however, not all carbohydrates can be considered
prebiotics.There are clear criteria thatmust be fulfilled to denote
a food ingredient as prebiotic, namely (1) non-digestible in the
upper gastrointestinal tract, thus reaching the colon intact.This
condition requires resistance to gastric acidity, hydrolysis by
mammalian enzymes and gastrointestinal absorption; (2) sus-
ceptibility to fermentation by the intestinal microflora; and (3)
ability to selectively stimulate the growth and/or activity of in-
testinal bacteria associated with health and well-being (Gibson
et al., 2004).
Several physiological benefits associated with the intake of
prebiotics have been recognized and almost all of them are a
consequence of the prebiotic ability to maintain or restore a
healthy gut microbiota. Generally, any dietary compound that
is non-digestible and is able to reach the large intestine can
potentially be classified as a prebiotic. Nevertheless, the cur-
rently accepted prebiotics are limited to a few non-digestible
oligosaccharides including fructans, galactans and lactulose
(Gibson et al., 2010). Lactosucrose is not yet included in this
group since some researchers considered it only as a poten-
tial candidate (Cho & Finocchiaro, 2010; Gibson et al., 2010).
Additional studies are still needed to unequivocally prove that
lactosucrose fulfils all the criteria to be considered a prebi-
otic ingredient. However, it is already known that lactosucrose
is barely digested in the upper gastrointestinal tract and it can
reach the colon almost intact (Oku, Tanabe, Ogawa, Sadamori,
& Nakamura, 2011). Moreover, some lines of evidence of the
potential prebiotic effect of lactosucrose were also reported for
humans and animals. One interesting characteristic of
lactosucrose is its laxative threshold. Lactosucrose presents a
higher laxative threshold when compared to other lactose-
based prebiotics (Oku & Okazaki, 1999), such as lactulose and
galacto-oligosaccharides (GOS). This fact represents an impor-
tant advantage because diarrhoea is frequently described as
a side effect of prebiotic intake (Vrese & Marteau, 2007). Ad-
ditionally, lactosucrose has a significant water-holding capacity,
which is considered an essential parameter both at physi-
ological and industrial levels. High water-holding capacity
increases bowel peristalsis and improves faecal formation and
output (Jie et al., 2000). In the food processing industry, the in-
crease of water-holding capacity can reduce syneresis or serum
separation during product storage (Krasaekoopt, Bhandari, &
Deeth, 2003). For consumer satisfaction, this is an important
aspect when considering fermented milk products, such as
yogurts or cheese, which are susceptible to serum or whey ac-
cumulation on the surface.The ability of lactosucrose to retain
water may suggest its use as a fat replacer in this kind of prod-
ucts, contributing to a decrease in syneresis and improving
some particular characteristics such as consistence and texture,
as it was already reported for inulin (Arango, Trujillo, & Castillo,
2013).
Lactosucrose has been widely used in the preparation of
functional foods, namely in Japan, where it was also in-
cluded in the list of foods for specific health uses (FOSHU), in
2005. The demand for lactosucrose has increased since then,
and in 2007 the market size of lactosucrose was estimated in
approximately 3000 tons per year with an annual growth rate
of 10% (Alfertsholt-Allen, 2007). Lactosucrose production is
achieved by enzymatic processes involving enzymes able to
catalyse both hydrolysis and transfer reactions. Different
enzymes can be involved in lactosucrose synthesis, but all of
them use the same substrates: lactose and sucrose. However,
the reaction yields are not particularly high due to the occur-
rence of product degradation. To efficiently respond to the
increasing demand of lactosucrose, it is important to improve
the process of synthesis, which can be achieved by finding new
and promising enzymes with enhanced catalytic activity, or by
developing efficient strategies to minimize product degradation.
2. Lactosucrose properties and stability
Lactosucrose (O-β-D-galactopyranosyl-(1,4)-O-α-D-
glucopyranosyl-(1,2)-β-D-fructofuranoside) is a synthetic
trisaccharide composed of galactose, glucose and fructose. It
can also be known as 4G-β-D-galactosylsucrose or lactosyl-
fructoside and presents a molecular weight of 504.44. Raffinose
(O-α-D-galactopyranosyl-(1,6)-O-α-D-glucopyranosyl-(1,2)-β-D-
fructofuranoside), naturally found in some vegetables, is an
isomer of lactosucrose and it can also present some poten-
tial prebiotic effect (Fernando et al., 2010).
Lactosucrose is obtained as a white solid with bland taste.
It can form small monoclinic platelets which are described as
very hygroscopic. The melting point of lactosucrose is around
181 °C and its specific rotation α[ ]D20 was determined as +59°
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(3.8 g/100 mL, H2O), which gives a molecular rotation [M]D of
29,730 (Avigad, 1957).
Fujita et al. (1991b) studied some physical properties of a
sugar mixture with 98% of lactosucrose (LS-98), obtained using
β-fructofuranosidase from Arthrobacter sp.The solubility of LS-
98 in water was found to be 3.67 g/L at 25 °C. Furthermore, its
sweetness was evaluated and it was found that LS-98 pres-
ents 30% of sucrose sweetness.The powder mixture presented
high hygroscopy, and when in solution (70% w/w), its water-
holding capacity was higher than that found for sucrose. The
water activity of LS-98 (70% w/w) was determined as 0.87 at
25 °C.The stability tests revealed that LS-98 was stable at pH 7.0
and 80 °C for 2 hours, and moderately stable under acidic pH
conditions (pH 3.0, 80 °C) where it showed some decomposi-
tion (less than 20%) after 2 hours. It was also stable for 1 hour
at pH 4.5 for temperatures up to 120 °C.
The use of lactosucrose as a sugar substitute in food was
evaluated by adding 10% (w/w) of a sugar mixture composed
of lactosucrose (35%, w/w, LS-35) and granulate sugar to agar
gels (0.5 and 1%, w/w). For 0.5% (w/w) agar gels, the addition
of LS-35 promoted a slight increase of syneresis after 24 and
48 hours of agar gel preservation at 6 °C. On the other hand,
for 1% (w/w) agar gels, LS-35 contributed to a slight decrease
in syneresis.This decrease was higher when the sweetener used
was composed of 100% LS-35 then when a mixture of LS-35
and granulate sugar (1:1) was added to agar (Hirota, Furuuchi,
& Mita, 1993).
When in contact with the reagents commonly used for sugar
analysis, lactosucrose proved to be non-reducing to the alka-
line copper reagent of Somogyi (1945) and it formed a green
colour upon reaction with diazouracil, a substance that is used
to specifically identify sucrose or sucrose-containing oligosac-
charides (Avigad, 1957).
Some tests to evaluate the enzymatic cleavage of
lactosucrose showed that this trisaccharide can be decom-
posed into equimolar amounts of fructose and lactose by an
invertase from yeast and into equimolar amounts of galac-
tose and sucrose by β-galactosidase. A combined action of
invertase and β-galactosidase allowed the total cleavage of
lactosucrose into glucose, galactose and fructose. When
lactosucrose was incubated with levansucrase, in the absence
of added aldose, three products were formed, namely levan,
fructose and lactose. On the other hand,when glucose was com-
bined with levansucrase, levan production decreased and a new
non-reducing product (not identified) was detected. Enzymes
like glucosucrase, dextran-sucrase, amylosucrase or yeast
glucosucrase were not able to decompose lactosucrose when
used separately. Nevertheless,mixed systems of β-galactosidase
and one of those enzymes had the ability to cleave lactosucrose
(Avigad, 1957).
Lactosucrose hydrolysis in supercritical water was inves-
tigated by Khajavi, Ota, Nakazawa, Kimura, and Adachi (2006)
using a continuous flow-type reactor and operating at 10 MPa
with different temperatures (200, 210 and 230 °C). For short resi-
dence times, decomposition of lactosucrose occurred with the
formation of approximately equimolar amounts of fructose and
lactose. Besides, no glucose or galactose were detected in those
residence times, which indicates that the bond α-Glc-(1→2)-
β-Fru is the most sensitive and susceptible for hydrolysis under
the studied conditions. Lactose hydrolysis took place for longer
residence times and it was confirmed by the detection of both
galactose and glucose. The increase of temperature posi-
tively affected lactosucrose hydrolysis, being faster at higher
temperatures (Khajavi et al., 2006).
3. Lactosucrose production
Avigad (1957) was probably the first to report the lactosucrose
production. In his original work, the author describes the en-
zymatic synthesis and characterization of a new non-reducing
trisaccharide (α-lactosyl-β-fructofuranoside) which was de-
nominated “lactsucrose”, later called lactosucrose. Levansucrase
from Aerobacter levanicum was the enzyme involved in the syn-
thesis, while sucrose and lactose were described as fructosyl
donor and acceptor, respectively. The author also added Toru-
lopsis glabrata cells to the reactionmixture to ensure continuous
removal of hexoses from the system and to prevent both in-
hibition and shift of levansucrase action.
Later, Fujita, Hara, Hashimoto, and Kitahara (1990a) de-
scribed the production and purification of an extracellular
β-fructofuranosidase from Arthrobacter K-1 with wide accep-
tor specificity. The transfructosylation ability of this enzyme
using lactose as acceptor was demonstrated (Fujita, Hara,
Hashimoto, & Kitahara, 1990b) and the process of lactosucrose
production was patented by Ensuiko Sugar Refining Co., Lda
(Fujita, Hara, Hashimoto, & Kitahara, 1992).
At an industrial level, lactosucrose can be obtained in a batch
reaction process through a transfructosylation reaction using
sucrose and lactose as substrates (Arakawa et al., 2002). The
enzyme involved is β-fructofuranosidase from Arthrobacter sp.
and lactosucrose is produced by incubating the enzyme with
both substrates and invertase-deficient yeast at 30–35 °C. The
yeast has an important role in removing the resulting by-
product glucose that can inhibit lactosucrose production
(Arakawa et al., 2002). This methodology offers a saccharide
mixture with about 65% of lactosucrose. However, higher
lactosucrose content (between 70 and 75%) and low amount
of by-products (less than 3%) can be achieved using other pat-
ented methodology for industrial application (Okabe, Aga,
Kubota, & Miyabe, 2008). This methodology combines the use
of β-fructofuranosidase from Bacillus sp. V230 and a sucrose-
unassimilable yeast, such as Saccharomyces cerevisiae. The yeast
is able to assimilate monosaccharides but it cannot consume
or hydrolyse oligosaccharides, including disaccharides (Okabe
et al., 2008).
The reaction involved in lactosucrose production can be de-
scribed as follows:
Sucrose Lactose Lactosucrose Glucose+ ↔ + (1)
where β-fructofuranosidase (such as levansucrase) catalyses
the transfer of the fructosyl residue from sucrose to lactose.
However, other compounds rather than lactose can act as ac-
ceptors, such as water or sucrose.When water is the acceptor,
a hydrolysis reaction occurs:
Sucrose Fructose GlucoseH O2⎯ →⎯⎯ + (2)
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If sucrose is the acceptor, the synthesis of fructoo-
ligosaccharide (FOS) takes place. Besides the transfer reac-
tions, the enzymes can also catalyse the parallel hydrolysis of
the newly formed product, which may compromise the
lactosucrose yields and productivity.
Another enzyme involved in the lactosucrose synthesis is
β-galactosidase, which catalyses the transfer of the galacto-
syl residue from lactose (donor) to sucrose (acceptor). Again,
the formed lactosucrose can also act as a galactosyl donor, thus
decreasing the yield.
Product degradation during the synthesis is a problem that
affects both enzymatic routes and strategies to avoid or
minimize this limitation ought to be developed. These
strategies may include the thermal deactivation of the
enzyme to discontinue the catalytic action (Pilgrim, Kawase,
Matsuda, & Miura, 2006) or the use of immobilized enzymes
which can be easily separated from the reaction products
(Mikuni et al., 2000). Alternatively, product degradation can
be controlled through process integration combining synthe-
sis and product separation. This strategy reduces the contact
time between enzyme and product and generally favours the
product formation and/or the elimination of potential inhibi-
tors (Kawase, Pilgrim, Araki, & Hashimoto, 2001; Pilgrim et al.,
2006).
Protein engineering can also give an important contribu-
tion to reduce product degradation by improving the catalytic
performance of the enzymes involved in the synthesis.The pro-
portion of transglycosylation to hydrolysis is dependent not
only on the reaction conditions, namely the ratio of donor to
acceptor, but also on the intrinsic properties of enzymes.
Different sources of enzymes can provide different trans-
glycosylation proportions, depending on the ability of the
enzyme to bind the acceptor and to exclude water. The un-
derstanding of the structures and catalytic mechanisms
involved in the enzymatic synthesis led to the development
of mutated enzymes with increased transglycosylation activ-
ity and/or reduced ability to hydrolysis (Ballesteros et al., 2007).
For example, Schroeven, Lammens, van Laere, and van den
Enden (2008) reported a drastic shift from water to sucrose as
preferred acceptor molecules, for mutant enzymes from Triti-
cum aestivum expressed in Pichia pastoris. A mutagenesis
approach applied to β-galactosidase from Geobacillus
stearothermophilus resulted in a simultaneous improvement of
the transglycosylation activity and reduction of hydrolysis to
potential transglycosylation products (Placier, Watzlawick,
Rabiller, & Mattes, 2009). Mutagenesis can also be useful to
provide enzymes with enhanced thermostability, an impor-
tant characteristic for the industrial use of enzymes (Ohta et al.,
2014; Yuan et al., 2008), or to minimize the effect of some in-
hibitors, such as galactose (Hu, Robin, O’Connell, Walsh, &Wall,
2010) or glucose (Trollope, Nieuwoudt, Görgens, & Volschenk,
2014).Additionally, the heterologous expression of enzymes has
been reported as a successful approach to achieve high levels
of extracellular enzyme (Gimeno-Pérez, Linde, Fernández-Arrojo,
Plou, & Fernandéz-Lobado, 2015; Oliveira, Guimarães, &
Domingues, 2011) which clearly facilitate its recovery and
further application.
Commercial lactosucrose production started in 1993 and the
Japanese-based companies Ensuiko Sugar Refining Co., Lda. and
Hayashibara Company are the main producers of this trisac-
charide (Fujita et al., 1992; McSweeney & Fox, 2009; Okabe et al.,
2008).
According to the literature, three different enzymes have
potential to be used as biocatalysts in the enzymatic synthe-
sis (Tables 1 and 2). Levansucrase and β -fructofuranosidase are
the most widely studied. β-Fructofuranosidase is generally ob-
tained from Arthrobacter sp., but for levansucrase, different
microbial sources have been evaluated. Recently, β-galactosidase
has also been reported for the production of lactosucrose (Li
et al., 2009).The different reaction conditions and catalysts used
in lactosucrose production will be discussed in the following
sections, where the use of commercial or industrial prepara-
tions of enzymes is differentiated from the use of integrated
processes of enzyme and lactosucrose production.
3.1. Integrated process of enzyme and
lactosucrose production
The integrated process involves both the enzyme production
and the lactosucrose synthesis. However, the biocatalysts used
in the process can present different forms such as isolated
enzymes or the whole cells. In the first case, two steps are in-
cluded: the production of a suitable enzyme and its further
application in lactosucrose production. Enzyme purification is
frequently performed prior to its use in the synthesis.The most
commonly techniques for enzyme purification are precipita-
tion with salts, centrifugation and chromatography. Purification
provides more active extracts and/or eliminates detrimental
compounds but it also represents an additional step to the
process. On the other hand, the use of whole cells as
biocatalysts does not require the isolation of the enzyme and
allows the simultaneous production of the enzyme and
lactosucrose.Alternatively, cultivated cells can be harvested from
the fermentation media by centrifugation and easily added to
the reaction mixture containing the substrates for the enzy-
matic synthesis. Both cases represent a reduction in the time
and/or costs associated to the process. Furthermore, enzymes
in cells tend to be more stable since they are protected from
external environment. However, it is important to highlight that
when using whole cells, many other enzymes, besides the
desired enzyme, are present in the reaction media, and con-
sequently, additional unwanted by-products may be formed
(Ishige, Honda, & Shimizu, 2005).
The reaction conditions and yields reported in the litera-
ture for lactosucrose production using free enzyme or whole
cells are summarized in Table 1. In almost all cases,
levansucrase was the enzyme involved in the synthesis;
however, different microbial sources have been described.
3.1.1. Free enzyme
Avigad (1957) obtained crude levansucrase from Aerobacter
levanicum (after cell disruption) and used it, for the first time,
to produce lactosucrose at pH = 5.4, with lactose in excess
(292 g/L lactose, 100 g/L sucrose) and in the presence of
T. glabrata cells. The reaction mixture was incubated at 30 °C
with toluene and was sporadically agitated.After 9 hours, fresh
sucrose was added to the reaction mixture and 13 hours later
the addition of ethanol (96% v/v) promoted the precipitation
of the enzyme and also some lactose. Chromatographic analy-
sis revealed that besides lactosucrose, a small amount of a
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Table 1 – Integrated process of enzyme and lactosucrose production.
Enzyme Microbial
source
Conditions
of use
pH Temp.
(°C)
Initial
substrate
concentration
(g/L)
Sugar
conversiona
(%)
Maximum
lactosucrose
production
(g/L)
Productivity
(g/L h)
Reference
Levansucrase Aerobacter
levanicum
Crude free
enzyme
5.4 30 292(lactose)
50(sucrose) at
the beginning
+50(sucrose)
after 9 hours
NIb NIb NIb Avigad, 1957
Levansucrase Bacillus natto Free purified
enzyme
6.2 35 85.5 (lactose)
85.5 (sucrose)
42 (lactose)
54 (sucrose)
53c 26.5 Takahama et al.,
1991
β-Fructofuranosidase Bacillus sp. 417 Crude free
enzyme
5.6 45 100 (lactose)
100 (sucrose)
NIb 54c 6.8 Ikegaki and Park,
1997
Levansucrase Paenibacillus
polymyxa
Free whole cells 6.0 55 225 (lactose)
225 (sucrose)
42 (lactose)
NIb (fructose)
170 28 Choi, Kim, Kim,
Jung, & Oh, 2004
Crude free
enzyme
6.0 40 225 (lactose)
225 (sucrose)
NIb 140c 210c
Levansucrase Bacillus
amyloliquefaciens
IFO15535
Free whole cells 6.0 55 24 (lactose)
34 (sucrose)
NIb 4.8 4.8 Park, Choi, & Oh,
2005
Bacillus subtilis
KCCM32835
6.0 55 225 (lactose)
225 (sucrose)
44 (lactose)
64 (sucrose)c
183 18.3
Geobacillus
stearothermophilus
ATCC12980
6.0 55 24 (lactose)
34 (sucrose)
NIb 10.4 10.4
Paenibacillus
polymyxa
KCCM35411
6.0 55 24 (lactose)
34 (sucrose)
NIb 14.1 14.1
Pseudomonas
syringae IFO14086
6.0 40 24 (lactose)
34 (sucrose)
NIb 3.9 3.9
Rahnella aquatilis
KCTC2858
6.0 40 24 (lactose)
34 (sucrose)
NIb 5.6 5.6
Sterigmatomyces
elviae ATCC18894
6.0 50 24 (lactose)
34 (sucrose)
NIb 7.5 7.5
Levansucrase Bacillus subtilis
NCIMB 11871
expressed in
Escherichia coli
Crude
recombinant
enzyme
6.0 NIb 410 (lactose)
205 (sucrose)
NIb (lactose)
77 (sucrose)c
131c 21.9 Seibel et al., 2006
Levansucrase Pseudomonas
aurantiaca
NIb 4.0 45 360 (lactose)
510 (sucrose)
NIb 285 142.5 Han et al., 2007
(continued on next page)
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Table 1 – (continued)
Enzyme Microbial
source
Conditions
of use
pH Temp.
(°C)
Initial
substrate
concentration
(g/L)
Sugar
conversiona
(%)
Maximum
lactosucrose
production
(g/L)
Productivity
(g/L h)
Reference
NIb Arthrobacter
mysorens ATCC
33408
Free whole cells 6.0 50 300 (lactose)
300 (sucrose)
NIb 15 1.0 Lee, Lim, Park,
et al., 2007
Klebsiella
pneumoniae ATCC
25306
Free whole cells 6.0 50 300 (lactose)
300 (sucrose)
NIb 16 1.1
Rahnella aquatilis
ATCC 55046
Free whole cells 6.0 50 300 (lactose)
300 (sucrose)
NIb 79 5.3
Sterigmatomyces
elviae ATCC
18894
Free whole cells
or mutant cells
immobilized on
calcium alginate
beads
6.0 50 300 (lactose)
300 (sucrose)
NIb 91 6.1
6.0 50 250 (lactose)
250 (sucrose)
NIb (batch) 192 (batch) 9.6 (batch)
NIb (continuous) 180 for 48 days
(continuous)
–
NIb Sterigmatomyces
elviae ATCC
18894
Mutant free
whole cells
6.0 50 250 (lactose)
250 (sucrose)
NIb 141 (basal
medium)
184 (optimal
medium)
9.4 (basal
medium)
12.3 (optimal
medium)
Lee, Lim, Song,
et al., 2007
Levansucrase Zymomonas
mobilis expressed
in Escherichia coli
Crude
recombinant
enzyme
7.0 23 180 (lactose)
180 (sucrose)
28 (lactose)c
66 (sucrose)c
103 25.8 Han et al., 2009
Levansucrase + glucose
oxidase
6.0 30 180 (lactose)
180 (sucrose)
33 (lactose)c
66 (sucrose)c
156 34.7
Levansucrase Bacillus
methylotrophicus
Crude free
enzyme
6.5 37 200 (lactose)
200 (sucrose)
40 (lactose) c
48 (sucrose)c
143 7.2 Wu et al., 2015
a When maximum lactosucrose production was obtained.
b NI, not indicated.
c Obtained from graphical extrapolation or text information and converted to appropriate units.
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fructose-containing non-reducing tetrasaccharide and a trace
of a fructose-containing reducing trisaccharide were also pro-
duced. The product was purified using a chromatographic
column containing Darco G-60 and Celite 535 (1:1) and it was
subsequently characterized. Nevertheless, no information about
the sugar conversion or lactosucrose yield was reported.
Takahama et al. (1991) used free levansucrase from Bacil-
lus natto to obtain lactosucrose. In this case, the enzyme was
previously purified by precipitation with ammonium sulfate
and through chromatographic methods. The enzymatic
reaction occurred at the optimal pH and temperature
found for levansucrase, i.e. 6.2 and 35 °C, respectively. Maxi-
mum lactosucrose production (approximately 53 g/L) was
obtained after 2 hours of reaction using an equal substrate
concentration. The production of lactosucrose by immobi-
lized levansucrase was also evaluated using different supports,
such as DEAE-Toyopearl 650M, hydroxyapatite and molecular
sieves of 5 Å. However, in all cases, lactosucrose production
was lower as compared to the results obtained for the free
enzyme.
Ikegaki and Park (1997) selected Bacillus sp. No. 417 as a
promising β-fructofuranosidase producer from a large number
of microorganism strains isolated from soil, flower and fruit
samples. Furthermore, this strain also presented high trans-
fer activity and proved to be able to produce lactosucrose, using
lactose and sucrose as substrates. The optimal conditions for
lactosucrose synthesis were established at 45 °C, pH 5.6, and
20% (w/w) of lactose and sucrose (ratio 1:1). Under these con-
ditions a concentration of 54 g/L of lactosucrose was obtained
after 8 hours of reaction, which is very similar to that re-
ported by Takahama et al. (1991).
Choi, Kim, Kim, Jung, and Oh (2004) studied the lactosucrose
production using levansucrase from Paenibacillus polymyxa. Dif-
ferent biocatalyst conditions were compared, namely crude free
enzyme and whole cells. Crude levansucrase was obtained after
cell disruption and subsequent precipitation of the superna-
tant with sodium sulfate. For free enzyme conditions,
approximately 140 g/L of lactosucrose were produced in 40
minutes. However, this lactosucrose concentration was lower
than that obtained when whole cells were used (seeWhole cells
section for further details).
The use of recombinant levansucrase to obtain lactosucrose
is also reported in the literature. Seibel et al. (2006) expressed
a recombinant levansucrase from Bacillus subtilis in Escheri-
chia coli and studied the acceptor specificity and catalytic
mechanism involved in the production of new sucrose ana-
logues and oligosaccharides. Productivity around 21.9 g/L h was
achieved for lactosucrose using lactose as the acceptor. In a
different study, recombinant levansucrase from Zymomonas
mobilis was expressed in E. coli and the enzymatic extract ob-
tained after cell disruption was used in lactosucrose synthesis,
without further purification (Han et al., 2009). Lactosucrose pro-
duction was investigated at the optimal conditions found (23 °C,
pH = 7.0, 18% (w/v) lactose and 18% (w/v) sucrose). Under these
conditions, a lactosucrose conversion efficiency of 28.5% was
obtained. With the aim to increase lactose and sucrose con-
version to lactosucrose, a mixed-enzyme system composed of
levansucrase and glucose oxidase was also tested. Glucose
oxidase contributed to reduce glucose content in the reac-
tionmixture, by converting glucose to gluconic acid. In addition,
it was demonstrated that the mixed-enzyme system in-
creased the efficiency of conversion to 43.2%.
In a brief abstract report, Han et al. (2007) described the
optimal conditions (45 °C, pH = 4.0, 36% (w/v) lactose and 51%
(w/v) sucrose) to produce lactosucrose using levansucrase from
Pseudomonas aurantiaca. After 2 hours of reaction, the
lactosucrose concentration reached 285 g/L, representing the
best yield found in the literature so far (Table 1). However, no
details on the conditions of use of the levansucrase were
reported.
The extracellular β-fructofuranosidase from Bacillus sp.V230,
previously described as catalyst for lactosucrose production in
the Japanese Patent Kokai No. 224665/97, was employed in a
new methodology patented by Okabe et al. (2008). The
enzyme was successfully used in combination with
Saccharomyces cerevisiae, which is able to consume the mono-
saccharides present in the reaction medium and consequently
enhance lactosucrose yield. In this methodology, crude
β-fructofuranosidase was concentrated and purified through
ion-exchange and hydrophobic chromatography prior to be
added to the reaction mixture containing 20% (w/w) of sucrose,
20% (w/w) of lactose and yeast cells. Lactosucrose synthesis
occurred at 30 °C, under pH conditions controlled to 4.0–5.5,
and provided a saccharide mixture with more than 70% of
lactosucrose after 24 hours (Okabe et al., 2008).
Recently, an intracellular levansucrase from Bacillus
methylotrophicus was described for lactosucrose production (Wu,
Zhang, Mu, Miao, & Jiang, 2015).The enzyme was obtained after
cell disruption and it was used without further purification in
the enzymatic synthesis under pH 6.5, 37 °C and 400 g/L sub-
strate concentration (lactose to sucrose 1:1). Maximal
lactosucrose concentration (143 g/L) was obtained after 20 hours
of reaction. The study showed that high substrate concentra-
tion has a positive effect in the lactosucrose production,
probably because at higher concentration, the substrate can
be more effective when competing with water to act as ac-
ceptor. The study also revealed that concentration ratio of
substrates has great influence in lactosucrose production.The
enzyme performance was considerably better when a ratio of
1:1 sucrose to lactose was used instead of 1:2 or 2:1 (around
100 g/L in both cases).
3.1.2. Whole cells
Choi et al. (2004) reported for the first time the use of whole
cells as biocatalysts in the lactosucrose production. These
authors obtained a higher lactosucrose concentration with
whole cells of Paenibacillus polymyxa when compared to free
levansucrase from the same microorganism.Whole cells also
presented a higher optimal temperature (55 °C). This fact can
justify the higher lactosucrose concentration observed because
increased temperature favours the substrate solubility and re-
action rate. Furthermore, the cell wall seemed to shield
levansucrase from denaturation caused by temperature. High
substrate concentrations (225 g/L lactose, 225 g/L sucrose) also
appeared to protect the enzyme in whole cells from denatur-
ation.Maximum lactosucrose production (170 g/L) was detected
after 6 hours of reaction.
Park, Choi, and Oh (2005) evaluated the production of
lactosucrose by several bacteria containing levansucrase ac-
tivity.A total of sevenmicroorganisms (Bacillus amyloliquefaciens,
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B. subtilis, G. stearothermophilus, Paenibacillus polymyxa, Pseudo-
monas syringae, Rahnella aquatilis and Sterigmatomyces elviae) were
selected and their efficiency to produce lactosucrose when using
whole cells was compared. The highest lactosucrose concen-
tration after 1 hour of reaction at optimal pH and temperature
was found for B. subtilis (15 g/L). Therefore, this microorgan-
ism was selected to be used in a further study in which the
substrate concentration was increased to the values previ-
ously reported by Choi et al. (2004): 225 g/L lactose and 225 g/L
sucrose. Under these conditions a maximal concentration of
183 g/L was reached after 10 hours of reaction, which repre-
sents an increase in lactosucrose production if compared
with the production achieved by Choi et al. (2004). However, a
higher reaction time was needed to obtain the maximum
concentration.
In a different study, Lee et al. (2007) evaluated the
lactosucrose-production activities of Arthrobacter mysorens, Kleb-
siella pneumoniae, Rahnella aquatilis and Sterigmatomyces elviae
in order to select the most promising microorganism to be used
in a continuous process of lactosucrose production involving
cell immobilization. Sterigmatomyces elviae presents a higher cell
size than bacteria, being more adequate for continuous pro-
duction in large scale. Furthermore, it also showed a higher
activity, providing a lactosucrose concentration of 91 g/L after
15 hours. However, its activity was considered reduced by the
authors and themicroorganismwas subsequently mutagenized
with N-methyl-N′-nitro-N-nitrosoguanidine in order to improve
the lactosucrose-production activity. Continuous production of
lactosucrose in a packed-bed reactor under optimized condi-
tions (pH = 6.0, 50 °C, 25% lactose and 25% sucrose) were
evaluated using the mutant whole cells immobilized in algi-
nate beads. It was shown that the feed flow rate can influence
lactosucrose production by accelerating the degradation of
sucrose and inhibiting the fructosyltrasfer reaction. A
lactosucrose production of 180 g/L was maintained for 48 days.
However, after that period of time the beads were swollen and
cell leakage occurred, leading to a decrease in the produc-
tion. In order to increase the cell mass and lactosucrose
production by Sterigmatomyces elviae, the same research group
optimized the culture media using analysis of variance (ANOVA)
and response surface methodology (RSM) (Lee et al., 2007). An
increase in lactosucrose concentration was obtained compar-
ing the results for the basal medium (140.91 g/L) and the
optimized medium (183.78 g/L). Furthermore, the experimen-
tal value obtained for lactosucrose was not distant from the
predicted maximum value determined (194.12 g/L).
3.2. Lactosucrose production using commercial/industrial
enzyme mixtures
Table 2 summarizes the results obtained for lactosucrose pro-
duction using commercial or industrial enzyme mixtures.
β-Fructofuranosidase is themost used enzyme and it was tested
both in free and immobilized conditions. β-Galactosidase is in-
troduced as an alternative to the conventional route of
lactosucrose synthesis using transfructosylation.
3.2.1. Free enzyme
Pilgrim et al. (2001) studied the lactosucrose production using
β-fructofuranosidase obtained from a sugar refining company.
They reported the transfructosylationmechanism as an ordered
bi-bi type where sucrose is first bound to β-fructofuranosidase
and lactosucrose is released afterwards. Furthermore, it was
shown that side reactions of sucrose and lactosucrose hydro-
lysis were inhibited by glucose and lactose, respectively, but
no inhibition effect was observed from fructose. In order to
improve the lactosucrose production and reduce side reac-
tions, Kawase et al. (2001) used a simulated moving bed reactor
(SMBR) and β-fructofuranosidase obtained from the same sugar
refining company. In this process, lactosucrose and glucose were
separated inside the reactor, migrating to the raffinate and
extract ports, respectively.Thus, enzymatic reaction and sepa-
ration occurred simultaneously, improving the lactosucrose
yield. Nevertheless, the expected lactosucrose yield was not
reached because strong product hydrolysis was detected around
the raffinate port. The maximum overall yield was 53% when
sucrose conversion reached 70%. To overcome this problem,
some changes were suggested, namely the enzyme cannot be
eluted into the raffinate port; the enzyme has to be inacti-
vated when it is eluted into the raffinate port; or the use of
SMBR with columns of immobilized enzyme. This process of
lactosucrose production using SMBR was later optimized
(Pilgrim et al., 2006).An appropriate model was developed taking
into account the effect of several process parameters, includ-
ing enzyme deactivation (to reduce produce hydrolysis). It was
shown that temperature influences both the sugar reaction rates
and the deactivation rate of the enzyme. The maximum pre-
dicted lactosucrose yield obtained by simulation was 69% at
65 °C.
The potential of β-galactosidase from B. circulans to produce
lactosucrose and other galactosylated derivatives using lactose
and sucrose as substrates was already reported (Farkas et al.,
2003; Li et al., 2008). Nevertheless, Li et al. (2009) showed for
the first time, in a complete study, the effectiveness of a com-
mercial β-galactosidase from B. circulans to catalyse lactosucrose
synthesis, being the chemical structure of the trisaccharide con-
firmed by NMR analysis. Besides lactosucrose, other transfer
products (tri- and tetrasaccharides) were detected and iden-
tified. Furthermore, it was shown that the amount and
composition of all transfer products changed considerably
during the enzymatic reaction. For that reason, the reaction
conditions (temperature, reaction time, substrate concentra-
tion, molar ratio donor/acceptor and enzyme concentration)
were optimized to increase the production of lactosucrose. A
maximum of 56 g/L of lactosucrose was obtained after 4 hours
of reaction under the optimal conditions.
3.2.2. Immobilized enzyme
As far as we know, the work from Mikuni et al. (2000) is the
only reference available in the literature regarding the use of
an immobilized enzyme for lactosucrose production. In this
work, β-fructofuranosidase from Arthrobacter sp. was ob-
tained from a sugar refining company and immobilized onto
a carrier resin (FE4611). The continuous production of
lactosucrose on a pilot plant scale was studied using a column
reactor containing the immobilized enzyme. The reactor was
successfully operated for 35 days, providing concentrations of
lactosucrose around 120 g/L. These results suggested the pos-
sibility of lactosucrose production at an industrial scale.
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Table 2 – Lactosucrose production using commercial/industrial enzyme mixtures.
Enzyme Microbial source Supplier pH Temp.
(°C)
Initial substrate
concentration
(g/L)
Sugar
conversiona
(%)
Maximum
lactosucrose
production (g/L)
Productivity
(g/L h)
Reference
β-Fructofuranosidase
immobilized on
carrier resin
(FE4611)
Arthrobacter sp. Ensuiko sugar
refining company,
Japan
6.5 55 200 (lactose)
200 (sucrose)
NIb 120c for 35 days
(continuous)
– Mikuni et al., 2000
β-Fructofuranosidase Arthrobacter sp. Ensuiko sugar
refining company,
Japan
NIb 50 137 (lactose)c
137 (sucrose)c
47 (lactose)c
56 (sucrose)c
93c 63.4c Pilgrim et al., 2001
NIb 43 137 (lactose)c
222 (sucrose)c
33 (lactose)c
25 (sucrose)c
202c 60.6c
β-Fructofuranosidase Arthrobacter sp. Ensuiko sugar
refining company,
Japan
NIb 50 181 (lactose)
171 (sucrose)
NIb (lactose)
70(sucrose)
133c (overall yield
53%)
9c (in the raffinate
after 1320 min)
using a simulated
moving bed reactor
NIb Kawase, Pilgrim,
Araki, & Hashimoto,
2001
β-Fructofuranosidase Arthrobacter sp. Ensuiko sugar
refining company,
Japan
NIb 50 342 (lactose)
342 (sucrose)
NIb 348c (overall yield in
the simulation 69%)
40c (in the raffinate
after 3005 min)using
a simulated moving
bed reactor
NIb Pilgrim, Kawase,
Matsuda, & Miura,
2006
β-Galactosidase Bacillus circulans Daiwa Kasei Co. Ltd.,
Japan
6 40 300 (lactose)
300 (sucrose)
70 (lactose)
47 (sucrose)
56 14 Li et al., 2009
a When maximum lactosucrose production was obtained.
b NI, not indicated.
c Obtained from graphical extrapolation or text information and converted to appropriate units.
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4. Lactosucrose quantification
and purification
Lactosucrose detection and quantification is essentially based
on chromatographic methods. In the first work describing
lactosucrose production, Avigad (1957) detected the presence
of lactosucrose using paper chromatography and specific re-
agents to identify fructose-containing saccharides.Additionally,
clear confirmation of the trisaccharide structure was ob-
tained from the information collected from differential
identification of glycosidic radicals using enzymatic re-
agents, from the products of lactosucrose oxidation with
periodate, and also from the value of optical rotation.
All other references about lactosucrose production de-
scribe high performance liquid chromatography (HPLC), with
refractive index or electrochemical detector, as the tech-
nique used for carbohydrate determination and quantification.
Nevertheless, different types of HPLC columns have been re-
ported for sugar separation, such as
• silica-based columns with: aminopropyl groups (Agilent
Zorbax NH2), secondary/tertiary amine (COSMOSIL Sugar-
D) or carbamoyl groups (TSKgel Amide-80), eluted with
mixtures of acetonitrile/water (Kawase et al., 2001; Lee et al.,
2007; Li et al., 2009);
• polymer-based columnwith amino groups (ShodexAsahipak
NH2P-50 4E), eluted with mixtures of acetonitrile/water (Wu
et al., 2015);
• C18-amine column (Kromasil KR100-10NH2) eluted withmix-
tures of acetonitrile/water (Han et al., 2009; Park et al., 2005);
• cation-exchange columns packed with sulfonated copoly-
mer in the sodium form (Na+) (Shodex Sugar KS-801) or in
the calcium form (Ca2+) (Rezex RCM-monossacharide Ca+2)
eluted with ultrapure water (Li et al., 2009; Seibel et al., 2006);
• anion-exchange columns packed with quaternary ammo-
nium functionalized stationary phase (Dionex, CarboPac PA1),
using gradient elution with NaOH and sodium acetate (Choi
et al., 2004).
To unquestionably confirm the presence of lactosucrose, its
structure can be determined by 1H and 13C NMR analyses after
separation and purification from the reaction mixture (Han
et al., 2009; Li et al., 2009; Seibel et al., 2006). Other alterna-
tive technique to assess carbohydrate structures could be mass
spectroscopy.The use of a separation technique, such as chro-
matography, coupled to mass spectroscopy, with electrospray
ionization (ESI) or matrix-assisted laser desorption/ionization
(MALDI), has been described for oligosaccharide separation and
analysis (Kailemia, Ruhaak, Lebrilla, & Amster, 2014). These
coupled techniques could also be suitable for lactosucrose sepa-
ration and detection. However, to the best of our knowledge,
there are still no reports on their use for this compound.
The composition of the sugar mixtures obtained at the end
of enzymatic synthesis of lactosucrose is dependent on the re-
action conditions and type of biocatalyst used.These mixtures
may contain variable amounts of unreacted substrates (lactose
and sucrose), glucose, fructose and galactose (formed from en-
zymatic hydrolysis of sucrose or lactose) and unknown
saccharides resulting from the transfer action of the enzymes.
The removal of monosaccharides, such as glucose and galac-
tose, can be easily achieved using microbial fermentation.
Suitable yeasts, like Saccharomyces cerevisiae, can successfully
reduce the amount of monosaccharides in sugar mixtures, by
fermenting them into ethanol and CO2, without any negative
effect on the oligosaccharide content (Hernandéz, Ruiz-Matute,
Olano, Moreno, & Sanz, 2009). Some patented methodologies
for industrial production of lactosucrose include this kind of
fermentation also for reducing enzyme inhibition by mono-
saccharides during the synthesis (Fujita et al., 1992; Okabe et al.,
2008).
Some lactosucrose purification can also be obtained using
SMB technology, as described in Section 3.2.This technique can
be applied to different kinds of chromatography and has been
used in the sugar industry for large scale separations (Geisser,
Hendrich, Boehm, & Stahl, 2005). In lactosucrose production,
the use of a SMB reactor composed of several columns filled
with ion-exchange resin (Amberlite) allowed the trisaccha-
ride separation from glucose during the enzymatic synthesis
(Kawase et al., 2001).
Lactosucrose has been isolated and purified from the re-
action mixture using conventional techniques, such as
decolonization and removal of unreacted substrates using ac-
tivated charcoal and Celite columns (Li et al., 2009); deionization
and separation of oligosaccharides using ion-exchange resins
(Seibel et al., 2006); or removal of the unreacted substrates by
crystallization (Okabe et al., 2008) or precipitation with ethanol
(Avigad, 1957).These techniques are described both for lab and
industrial purification of lactosucrose.
Lactosucrose crystallization from its supersaturated solu-
tion can be achieved using temperature control and addition
of organic solvents, such as methanol, ethanol and acetone to
control the degree of supersaturation and viscosity (Okabe et al.,
2008).
There are also some techniques described in the litera-
ture for the separation and purification of oligosaccharide
mixtures which could be adequate for mixtures containing
lactosucrose. For example, nanofiltration using suitable ultra-
filtration membranes (Goulas, Kapasakalidis, Sinclair, Rastall
& Grandison, 2002) and supercritical extraction based on carbon
dioxide (Montañés, Olano, Reglero, Ibáñez & Fornari, 2009) were
successfully used to fractionate and concentrate mixtures of
oligosaccharides. Nevertheless, as far as we know there are no
reports on their use for lactosucrose.
5. Benefits associated to lactosucrose
ingestion
Several physiological benefits associated with the consump-
tion of lactosucrose have been reported. These benefits result
essentially from its resistance to digestion and ability to be fer-
mented by intestinal microbiota. Lactosucrose, as a potential
prebiotic, has an important role in themodulation of microbiota
composition. Furthermore, microbial fermentation of
lactosucrose generates interesting end products such as short-
chain fatty acids (SCFAs). These compounds have recognized
beneficial effect to the host by reducing the pH and enhanc-
ing mineral bioavailability (Roberfroid et al., 2010). Intestinal
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fermentation of lactosucrose, as well as its positive action in
health, has been demonstrated using both in vitro and in vivo
studies with humans and animals.The physiological action and
practical effects of lactosucrose consumption are summa-
rized in Table 3.
5.1. In vitro studies
The in vitro studies performed with lactosucrose were essen-
tially focused on its resistance to digestion and its ability to
be selectively fermented by intestinal microbiota.
Lactosucrose resistance to digestion in the upper gastro-
intestinal tract was confirmed in a comparative in vitro study
using human and rat small intestinal homogenates.The results
obtained indicated that lactosucrose was barely hydrolysed and
the hydrolysing activity was similar for human and rat intes-
tinal enzymes (Oku et al., 2011).
In vitro fermentation of lactosucrose was evaluated using
potential probiotic stains such as Lactobacillus, Bifidobacterium
and Streptococcus and it was observed that lactosucrose pro-
moted the growth of four bacterial strains (Streptococcus
salivarius, Lactobacillus casei, Lactobacillus reuteri and Lactobacil-
lus acidophilus) out of seven tested (García-Cayuela et al., 2014).
In fishes, in vitro fermentation of lactosucrose was demon-
strated using intestinal microbiota collected from the
carnivorous teleost Pagrus major (Kihara, Ohba, & Sakata, 1995),
the carp Cyprinus carpio L. (Kihara & Sakata, 2002) and the
rainbow trout Oncorhynchus mykiss (Kihara & Sakata, 2001).The
degree of fermentation was evaluated by the release of gases
and the production of SCFAs. The results obtained demon-
strated that in vitro fermentation of lactosucrose can occur in
herbivorous, omnivorous and carnivorous fishes (Kihara et al.,
1995).
The increase of bifidobacteria and lactobacilli populations
and the reduction of the numbers of bacteroides and clos-
tridia confirmed the occurrence of in vitro digestion of
lactosucrose by the human intestinal microbiota (Li et al., 2015).
The production of SCFAs was also observed.
5.2. In vivo studies with animals
The effects of lactosucrose consumption were evaluated in
several animals and positive results were obtained (Table 3).
The enhancement of beneficial bacteria, such as Lactobacillus
and Bifidobacterium spp., and the inhibition of pathogenic bac-
teria, like Clostridium perfringens or Bacteroidaceae, was observed
after lactosucrose consumption by rats (Yoneyama et al., 1992b),
broiler chickens (Terada et al., 1994), shepherd dogs (Terada
et al., 1992) or cats (Terada et al., 1993). In some cases, all these
parameters returned to normal when lactosucrose was removed
from diet (Yoneyama et al., 1992b).
Production of SCFAs, like acetic and butyric acids, and con-
sequent reduction in the pH of faecal contents were also noticed,
confirming the lactosucrose fermentation by the microbiota
Table 3 – Physiological action of lactosucrose and its practical effects in animals and humans.
Animal Human
Physiological
action
Enhancement of beneficial bacteria
and/or inhibition of pathogenic
bacteria
Rats (Honda et al., 1999; Yoneyama
et al., 1992b)
Dogs (Terada et al., 1992)
Cats (Terada et al., 1993)
Chickens (Terada et al., 1994)
Fujita et al., 1991a; Iwagaki et al.,
1991; Kumemura et al., 1992; Iwagaki
et al., 1993; Takumi et al., 2001;
García-Cayuela et al., 2014; Li et al.,
2015
Decrease of faecal pH, production of
SCFAsa and gases, reduction of
putrefactive products
Rats (Yoneyama et al., 1992b)
Dogs (Terada et al., 1992)
Cats (Terada et al., 1993)
Chickens (Terada et al., 1994)
Fishes (Kihara et al., 1995; Kihara &
Sakata, 2001; 2002)
Kumemura et al., 1992
Enhancement of intestinal absorption
of minerals
Rats (Fujita et al., 1999; Kishino et al.,
2006)
Fishes (Kihara et al., 2007)
Teramoto et al., 2006
Practical
effects
Prevention of obesity Rats (Mizote et al., 2009; Okuda & Han,
2001)
–
Improvement of the immune
response
Rats (Hino et al., 2007)
Fishes (Chu et al., 2013)
–
Prevention of allergic diseases Rats (Taniguchi et al., 2007) –
Reduction of faecal odour Dogs (Terada et al., 1992)
Cats (Terada et al., 1993)
Chickens (Terada et al., 1994)
Kumemura et al., 1992
Treatment of chronic inflammatory
bowel diseases
Rats (Honda et al., 1999; Zhou et al.,
2014, 2015a, 2015b)
Teramoto et al., 1996
Contribution to calcium accumulation
in bones
Rats (Fujita et al., 1999; Kishino et al.,
2006)
Teramoto et al., 2006
Normalization of intestinal microflora Rats (Honda et al., 1999) Iwagaki et al., 1991; Iwagaki et al.,
1993
Prevention of abdominal symptoms of
lactose intolerance
– Oku, Kasagi, Sawatani, Fukuda &
Kurimoto, 2002
a SCFAs – short chain fatty acids.
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(Terada et al., 1992, 1993, 1994; Yoneyama et al., 1992b). Fur-
thermore, a decrease in putrefactive substances, such as
ammonia, phenol or skatole, was observed, which contributed
to a reduction of faeces odour (Terada et al., 1992, 1993, 1994).
The production of SCFAs by lactosucrose fermentation lowers
the intestinal pH value, which has a practical effect in the en-
hancement of calcium solubility and consequently its
absorption from the intestine. Calcium distribution and accu-
mulation in bones can be followed through 45Ca administration
into the stomach or analysed by X-ray densitometry. Rats fed
with lactosucrose presented a significant increase of calcium
accumulation in femur and tibia, suggesting that lactosucrose
consumption can stimulate osteogenesis and help in the main-
tenance of bone strength (Fujita et al., 1999; Kishino et al., 2006).
The ingestion of lactosucrose increased calcium retention not
only in mammals but also in marine teleosts. Studies carried
out with red sea bream Pagrus major showed that dietary
lactosucrose affected the calcium metabolism, leading to a
greater increase of calcium content in scales (Kihara, Kiryu,
& Sakata, 2007).
Furthermore, lactosucrose can have a trophic effect by stimu-
lating the growth of intestinal tunicamuscularis, which resulted
in increased thickness and toughness of this muscular layer
in Pagrus major (Kihara et al., 1995).
The maintenance of intestinal microflora in the small in-
testine of rats also resulted in a protective effect on intracolonic
indomethacin-induced ulcers (Honda et al., 1999).
Other practical effect of lactosucrose intake was the inhi-
bition of the 2-mono-oleoyl-glycerol absorption by the brush
border membrane vesicles and also the reduction of plasma
triacylglycerol levels in female mice (Han et al., 1999). More-
over, lactosucrose caused a reduction in the parametrial adipose
tissue weight in rats (Okuda & Han, 2001) due to the suppres-
sion of body fat accumulation. For that reason, lactosucrose
was suggested as a promising dietary supplement for obesity
prevention (Mizote et al., 2009).
Lactosucrose supplementation can positively affect the
serum metabolome in trinitrobenzene sulfonic acid-induced
colitic rats, resulting in a beneficial protection to the host against
ammonia toxicity and oxidative injury (Ruan et al., 2013). The
potential nutraceutical action of lactosucrose on the combat
of colitis in rats was demonstrated by its positive effect on the
prevention or inhibition of trinitrobenzene sulfonic acid-
induced chronic inflammation (Zhou et al., 2014, 2015b).
Therefore, lactosucrose can be used as a functional food for
patients with inflammatory bowel disease (Zhou et al., 2015a).
The changes that occurred in the intestinal environment
of microflora of rats after lactosucrose ingestion can indi-
rectly enhance the levels of immunoglobulin A, an antibody
which has an important role in mucosal immunity (Hino et al.,
2007). As a result, lactosucrose can indirectly regulate mucosal
immune response. Furthermore, lactosucrose supplementa-
tion to mice had a suppressive effect on antigen-specific
immunoglobulin E (IgE) production, which suggested the po-
tential use of lactosucrose in the prevention of IgE-mediated
allergic diseases (Taniguchi et al., 2007).
The addition of lactosucrose to the conventional diet of grass
carp juveniles (Ctenopharyngodon idella) showed an improve-
ment in the growth performance, surviving rate and immunity
of the specie. Moreover, the results obtained suggested the po-
tential use of lactosucrose as an alternative dietary antibiotic
in fish aquaculture (Chu et al., 2013).
5.3. In vivo studies with humans
There are also some studies reporting the effect of lactosucrose
on humans (Table 3). Lactosucrose consumption by healthy
adults (Fujita et al., 1991a; Hara et al., 1994; Ogata et al., 1993;
Takumi et al., 2001; Yoneyama et al., 1992a) and elderly pa-
tients with constipation (Kumemura et al., 1992) had a positive
impact in the number of beneficial bacteria, such as Lactoba-
cillus and Bifidobacterium spp., and a detrimental effect on the
number of pathogenic bacteria, like Clostridia sp. Further-
more, the levels of blood glucose or serum insulin were not
significantly changed after lactosucrose ingestion (Fujita et al.,
1991a) by healthy adults. The most significant changes oc-
curred on faecal pH, which suffered a considerable reduction
due to the production of SCFAs, namely acetic and n-butyric
acids (Kumemura et al., 1992). The concentration of harmful
putrefactive products in faeces, such as p-cresol, indole, skatole
and ammonia, was also reduced (Kumemura et al., 1992).
Lactosucrose intake can have a practical effect in the in-
crease of stool frequency, faecal weight and moisture.
Furthermore, the subject sensation of defection can be im-
proved after lactosucrose ingestion and inconvenient symptoms
such as abdominal pain, distension, stomach rumble, or nausea
were not reported (Kumemura et al., 1992).
The administration of lactosucrose had a positive impact
in the recovery of colonic environment in patients with re-
sected colon (Iwagaki et al., 1991) and also in normalization
of the intestinal microflora in a female patient suffering from
diarrhoea after total colectomy (Iwagaki et al., 1993).
Lactosucrose can also have a beneficial effect in the treat-
ment of patientswith chronic inflammatory bowel diseases, like
Crohn’s disease and ulcerative colitis (Teramoto et al., 1996).The
prevention of abdominal symptoms in lactose-intolerant pa-
tients canbeachievedby theadministrationof lactosucrose (Oku,
Kasagi, Sawatani, Fukuda, &Kurimoto, 2002).Additionally, long-
term consumption of lactosucrose enhanced the intestinal
absorption of calcium,magnesiumandphosphorus and reduced
bone resorption in healthy youngwomen (Teramoto et al., 2006).
The effective dosage of lactosucrose with physiological effect
on faecal flora and faecal metabolites for healthy humans was
determined as 1–3 g/day (Hara et al., 1994; Ogata et al., 1993;
Yoneyama et al., 1992a). Furthermore, the ingestion of a given
daily amount of lactosucrose divided into two or more doses
reduced the occurrence of diarrhoea comparatively to the in-
gestion of the same amount in a single dose (Oku & Okazaki,
1999). The laxative threshold of lactosucrose was determined
as 0.802 g/kg body weight, which is significantly higher than
those reported for other non-digestible carbohydrates such as
the disaccharide lactulose (0.26 g/kg body (Oku & Okazaki, 1998)).
6. Potential applications of lactosucrose
In the past two decades, a large number of functional foods
containing lactosucrose have been introduced into the market.
In Japan, lactosucrose was classified as FOSHU ingredient and
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it is widely used in diverse healthy foods and drinks to modify
gastrointestinal conditions and improve well-being.
Lactosucrose, as a low-digestive and low-cariogenic sweet-
ener, can be included in foods and beverages such as bakery
products (Ueda et al., 2000), yogurts (Takumi et al., 2001), ice
creams, infant formula, snacks, cookies, desserts or candies
(Naito, Aoyama, Fujita, & Takahashi, 1994). Its incorporation
in chocolates, chewing gum, instant juice, instant soup and
mineral water was also claimed in several patents (Fujii,
Mizoguchi, Okimura, & Shinoda, 2006; Okabe et al., 2008).
Furthermore, lactosucrose was added to pet food to simul-
taneously regulate intestinal microflora and reduce the
unpleasant odour of faeces and urine (Fujimori, 1994), and also
to fish feed to improve nutrient absorption and decrease self-
contamination by excretion (Kihara et al., 2001).
The application of lactosucrose in pharmaceutical and cos-
metic products was described in some patents, where it acts
as excipient (Bassarab et al., 2005), as nutritional support and
microflora regulator (Garssen, van Tol, Jben, & Verlaan, 2009),
or as active ingredient in the prevention of some skin dis-
eases (Nobuaki, 1998).
Additional applications of lactosucrose include its use to
mimic transglycosylation products in enzymatic tests of hy-
drolysis by mutated β-galactosidase (Placier et al., 2009), to
induce the production of α-galactosidase (Rezessy-Szabó et al.,
2003), and to stabilize proteins (Schüle, Schulz-Fademrecht,
Garidel, Bechtold-Peters & Frieβ, 2008) or polyplexes (Kasper,
Schaffert, Ogris, Wagner, & Friess, 2011).
The diversity of lactosucrose applications proposed since
its commercial production reflects its great potential. Hence,
the use of lactosucrose is not restricted to the examples de-
scribed herein and it is expected that new and attractive
applications will emerge in the near future.
7. General conclusions and future
perspectives
Lactosucrose presents interesting physical and chemical prop-
erties whichmake it an attractive and advantageous substitute
to the conventional sugar. Furthermore, its hydrolysis by intes-
tinal enzymes is apparently very low,while its fermentation by
intestinal microflora seems to be high. This important feature
is associated to numerous beneficial effects to health and has
been extensively explored during the past decades. New and
promising applications of lactosucrose have been proposed, and
consequently, the demand for lactosucrose has significantly in-
creased.Besides its importance in themedical area for treatment
of some specific diseases, the consumption of lactosucrose in
the formof functional foods has beenwidely associated to good
health practices and improvement ofwell-being.For that reason,
lactosucrose has been incorporated in food and beverages, in
dietary supplementsandalso inanimal feed.Lactosucrosemarket
is expected to increase, and as a result, the development of ef-
ficient strategies for its synthesis is of utmost importance.
The enzymatic production of lactosucrose was essentially
based on the ability of levansucrase or β-fructofuranosidase
to catalyse the hydrolysis of sucrose and subsequent transfer
of fructosyl moiety to the acceptor lactose. Alternatively,
β-galactosidase was successfully proposed as biocatalyst for
the production of lactosucrose. The optimal reaction condi-
tions for lactosucrose synthesis depend both on the type of
enzyme and on the microbial source. In the same way, the
product composition obtained at the end of the reaction is
strongly dependent on the biocatalyst used and its ability to
catalyse transfer reactions.
Protein engineering can provide a crucial contribution to
the enhancement of lactosucrose yield. New mutants can be
obtained with interesting specificity such as improved
transglycosylation activity or reduced capacity to lactosucrose
hydrolysis. This allows the possibility to guide the enzymatic
reaction towards the synthesis of the desired compounds.
For lactosucrose, besides the challenge of enhancing the
reaction yield, it is also necessary to validate it as an unques-
tionable prebiotic to be accepted by the scientific community.
Lactosucrose already showed promising features as prebi-
otic; however, more clinical studies are needed to obtain robust
data about the lactosucrose effect in humans.Additional in vitro
and in vivo tests involving a large number of individuals have
to be performed to definitely confirm its resistance to diges-
tion in the upper gastrointestinal tract, its susceptibility to
fermentation by the intestinal microflora and also its capa-
bility to selectively stimulate the growth and/or activity of
intestinal bacteria, namely Bifidobacterium and Lactobacillus
genera. Furthermore, a detailed study about lactosucrose fer-
mentation and decomposition by gut microflora can provide
valuable information and contribute to the design of novel com-
pounds with improved properties and enhanced prebiotic effect.
There is an increasing interest in finding prebiotics which could
offer a higher activity at lower dosages, higher persistence in
the colon without side effects, good storage and processing sta-
bility, and also additional biological activities.
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